ABSTRACT Background
Objective
The objective of this study was to screen Ser315Thr mutation of KatG gene of INH resistant MTB strain by PCR-RFLP technique.
Methods

Altogether 37 INH
r MTB isolates obtained from German Nepal Tuberculosis Project (GENETUP) Kathmandu Nepal was included in the study. Deoxyribonucleic Acid (DNA) extraction was performed according to protocol of SORPOCLEAN™ from the culture isolates. Amplification of the fragment with katG codon 315 was performed in a Biometra Thermocycler using primers. The amplified fragment was cleaved with MspI. The restriction fragments obtained were electrophoresed in a 2% agarose gel and were visualized using transilluminator.
Results
The katG Ser315Thr mutation was observed in 23 (62.2%) out of 37 INH resistant isolates. The drug susceptibility profile of INH r MTB isolates showed all isolates to be resistant to INH and RFP whereas 26 and 27 MTB isolates were resistant to Ethambutol (EMB) and Streptomycin (S) respectively. Seventeen (17) patients were harbouring katG gene mutated strain among Ethambutol and Streptomycin resistant cases.
Conclusion
The study identified high prevalence of Ser315Thr mutation in katG. The isolates harbouring this mutation were also simultaneously resistant to RFP. Ser315Th could be a potential genetic marker for predicting MDR-TB.
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Original Article pyrizinamide and ethambutol (HRZE) to ensure that the mutants resistant to even a single drug do not emerge. In next four months only isoniazid and rifampicin are administered to eliminate any persisting tubercle bacilli.
INTRODUCTION
Tuberculosis (TB) is the leading cause of mortality and accounts for 26% of all preventable adult deaths globally. 1 According to WHO, 8 million cases of TB occur each year, resulting in 3 million deaths. In addition overall one third of worlds' population is currently infected with the TB bacillus, 5-10% becoming sick at sometime during their lifetime. 2 Currently TB is treated with an initial two month regimen comprising multiple antibiotics-isoniazid, rifampicin, incidence. The prevalence of mutations at codon 315 varies greatly in different geographical regions. 4 The prevalence of the katG (AGC ACC) mutation among MDR-MTB strains in the world, varies, being low in area with low TB incidence and high in area with high TB incidence. 5 China and India carry almost 50% of worlds MDR-TB burden. 6 Nepal, being geographically situated between these two nations with open border with India cannot be undermined for upcoming alarming situation of MDR-TB epidemics. Thus, detection of mutation in katG gene in Nepalese strains finds its rationale. The magnitude and trends in MDR tuberculosis are epidemiologically important to monitor, the estimation of the burden of disease is programmatically relevant in shaping policies for screening and treatment. The objective of this study was to screen Ser315Thr mutation of KatG gene of INH resistant MTB strain by PCR-RFLP technique.
METHODS
A total of 37 strains recovered from different adult patients (age range from 15 to 68 years) were studied. These patients originated either from Lalgadh hospital, Janakpur; Birjung Medical College, Birjung; GENETUP, Kathmandu and National Tuberculosis Centre, Bhaktapur. In Nepal, German Nepal Tuberculosis Project (GENETUP) is the national reference centre for drug susceptibility testing for mycobacteria, and receives all specimens detected in the country as a whole. Clinically and epidemiologically relevant information from each patient was obtained.
DNA Extraction from MTB isolates
DNA extraction was done as guided by General Protocol for high DNA specimen of SORPOclean™. A loopful of each bacterial growth on Lowenstein Jensen medium was suspended in 1ml distilled water, warmed to room temperature (15-20°C) . The 20µl proteinase K solution 200µl of sample and 200µl of lysis solution was added in 1.5 ml microcentrifuge tube. After vortexing (Taurus Scientifica) for 2-3 min. and incubation (56°C/10min), 230µl of 96% ethanol was added and mixed, and then the mixture was transferred into column. It was then centrifuged in a research centrifuge (REMI Instruments) at 6000g for 1min.Washing was done using Wash solution 1 and Wash solution 2 respectively with 500µl each. Finally 100µl of elution buffer pre-warmed at 70°C was added to elute purified DNA. The purity of DNA was determined by A260/A280 (optical density of DNA measured at 260 and 280 nm) using spectrophotometer (Thermoscientific).
PCR procedure for katG gene amplification
Amplification of fragment with katG codon 315 was performed in a Biometra Thermocycler with primers [Operon, Lot#1188685] katG F (5'AGCTCGTATGGCACCGGAAC3') and katG R (5'AACGGGTCCGGGATGGTG3') in a 25µl of a PCR mixture (1 U Taq DNA polymerase; 200µM each dNTP's; 1.5mM Mgcl 2 ; 15pmol of each primer; 2.5 µl of buffer [Fermentas, lot#00022114] ; 1µl DNA sample) under the following condition (Initial denaturation at 95°C/10min; 30cycles of 94°C/1min; 55°C/1min ; 72°C/1min and a final elongation at 72°C/4min). Control reactions for detection of false positive results due to contamination with previously amplified amplicons were performed as follows: a negative control (distilled water) was included in each PCR run; no contamination was detected. A control sample (DNA extracted from INH S -H37Rv; Gene Bank accession no: X68081) was included in each PCR run; it showed clear band at 153bp
Agarose gel electrophoresis
The amplicons were detected by 2% agarose gel electrophoresis stained with e ethediul bromide. MTB strain H37Rv and a PCR reaction without MTB DNA were used as positive and negative control in the PCR reaction respectively.
Screening of mutation by RFLP
PCR amplicons were digested by MspI (Fermentas, lot no# ER 0541) incubating the mixture containing 10µl PCR product; 17.0µl NFW; 2µl 10x buffer tango (Fermentas, lot no# 00033251) and 1.0µl MspI, at 37°C/3 hours. The mutation AGC (Ser) to ACC(Thr) creates an additional MspI site (CCGG) and thus can be detected by use of this restriction endonuclease As a result, the longest RFLP product obtained was 132bp for INH r isolates with mutated 315 ACC allele and 153bp for katG codon 315 wild type or differently mutated allele. The digested products were detected by 2% agarose gel electrophoresis stained with ethediul bromide. MTB strain H37Rv, wild type was used as a control in the digestion.
These indicative bands could be clearly discriminated in 2% agarose gel electrophoresis; they were the only visible bands, while 10 to 21 bp bands ran out of gel and were not considered. The electrophoresis was performed as described above.
Data analysis
Data were analyzed manually as well as using SPSS Version16 and findings were interpreted according to frequency distribution and percentage. Data were presented in tables and figures.
Ethical approval for the study was taken from Institutional Review Board Kathmandu University School of Medical Sciences Dhulikhel Nepal.
RESULTS
Using the katG primers, amplicons were detected in 37 isolates. RFLP analysis of 37 katG gene showed Ser315Thr mutation in 23 (62.2%) MTB strains. The RFLP pattern for isolates is shown in figure 1 . As per sex-wise distribution, the male patients outnumbered females. Among 25 male subjects 18 (72%) were harbouring mutated strain of MTB and 7(28%) were harbouring wild type or differently mutated strain. Among 12 female subjects 5 (41.6%) were harbouring mutated strain of MTB and 7(58.4%) were harbouring wild type or differently mutated strain as shown in table 1.
As per resistance pattern of other first line drugs among MDR-MTB isolates with katG gene mutated and Wild type (WT) or differently mutated cases. 17 (73.9%) each were found to harbor cross-resistance with ethambutol and streptomycin.
As depicted in Table 2 , the drug susceptibility profile of MDR-MTB isolates showed that poly-drug resistance pattern predominated with 62.1% being resistant to HRSE; 13.5% with HRS and 5.4% with HRE. However, no monodrug resistant to either H or R was observed. The highest no. of katG mutation was found in HRSE resistant strains. 
DISCUSSION
Multidrug resistant tuberculosis is entirely a man made phenomenon 3 but not due to emergence of novel resistance mechanism
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; whereby MTB bacilli acquire resistant to at least isoniazid and rifampicin. 3 The ability of DOTS programs to reduce transmission and incidence of both drug susceptible and drug-resistant tuberculosis is debatable; while some studies have shown successful reduction of drug resistance under WHO strategy, others have demonstrated an "amplifier effect" of increasing drug resistance under DOTS-prescribed short course therapy. 8 The most frequent mutation patterns of isoniazid, rifampicin and streptomycin resistant strain occurred at codon 315 (55-90%) of katG; codon 531 (40-60%) and codon526 (10-30%) within RPF resistance determining region of rpoB; and codon 43 (47-79%) of rpsL within Streptomycin resistant MTB. Mutation in katG gene occurs in a 100 fold higher frequency than rpoB gene 9 and is regarded as first step in evolution of MDR-MTB [10] [11] [12] [13] and also creates more possibility for acquiring mutations in other genes. [13] [14] [15] The combination of INH resistance and maintained virulence might make it possible for some INH resistant strains, especially those with the katG Ser315Thr mutation, to acquire extra drug resistance and become MDR-TB. 13 The molecular basis of resistance to isoniazid is more complex and is caused by a variety of mutations in four different genes of MTB i.e. katG encoding catalase peroxidase, inhA encoding the enoyl acyl carrier protein (ACP) reductase, kasA encoding β-ketoacyl ACP synthase and ahpC encoding alkyl-hydroperoxide reductase e.t.c. Even then, nearly 5-10% of isoniazid-resistant M. tuberculosis isolates do not have an identifiable mutation.
This study was conducted to gain further insight into molecular basis of INH r MTB circulating in Central development region of Nepal. We found that mutation in katG gene (Ser315Thr substitution) was responsible for 62.2% of INH r strains. We compared our result of mutation at katG codon 315 associated with INH resistance and results of demographic findings with those of earlier studies done worldwide.
The prevalence of katG S315T substitution in MTB strains vary all over the world especially with regard to TB prevalence. [17] [18] [19] In place like Singapore 20 31 Furthermore, in current study we found number of male patients outnumbering the number of female patients with INH resistant isolates. In a molecular epidemiological study of Hu Yi et al., 13 in eastern China similar type of finding was stated where male outnumbered female patients with average age being 30 years. Similarly in his study, Pandey R.P 32 in Doti district of Western region of Nepal also found male patients outnumbering female patients with average age of male being 36.7 and female being 33.7 suggesting that the prevalence of MDR-TB within the country may vary among different age groups.
Early detection of the patients carrying INH resistant strains would facilitate the modification of treatment regimens and appropriate infection control measures can be taken in time to reduce the risk of further development and transmission of MDR-TB. An understanding on the molecular level of the mechanism of drug resistance in MTB will enable us to develop improved tools. It deserves further investigation to determine which mechanism may play the critical role in the epidemic of MDR-TB, since the implication behind it could be meaningful to evaluate the performance of local TB control as well as to determine the MDR-TB strategies.
CONCLUSION
The study identified high prevalence of Ser315Thr mutation in katG. The isolates harbouring this mutation were also simultaneously resistant to RFP. Ser315Th could be a potential genetic marker for predicting MDR-TB. The molecular detection of this mutation by PCR-RFLP in TB control programmes could help in early detection, management and containment of MDR-TB cases.
